loader

atxs:us

LATEST ARTICLES
Astria Therapeutics Initiates the Phase 3 ORBIT-EXPANSE Long-Term Trial of Navenibart in People with Hereditary Angioedema
Base Metals Investing

Astria Therapeutics Initiates the Phase 3 ORBIT-EXPANSE Long-Term Trial of Navenibart in People with Hereditary Angioedema

Astria Therapeutics to Present at Upcoming 2025 HAEi Regional Conference EMEA
Base Metals Investing

Astria Therapeutics to Present at Upcoming 2025 HAEi Regional Conference EMEA

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 - October 02, 2025
Base Metals Investing

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 - October 02, 2025

Astria Therapeutics Now Enrolling HAE Patients in the European Union for the Phase 3 ALPHA-ORBIT Trial
Base Metals Investing

Astria Therapeutics Now Enrolling HAE Patients in the European Union for the Phase 3 ALPHA-ORBIT Trial

Astria Therapeutics Announces Positive Initial Results from the Phase 1a Healthy Subject Trial of STAR-0310 at the European Academy of Dermatology and Venereology
Base Metals Investing

Astria Therapeutics Announces Positive Initial Results from the Phase 1a Healthy Subject Trial of STAR-0310 at the European Academy of Dermatology and Venereology

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 - September 03, 2025
Base Metals Investing

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 - September 03, 2025

Astria Therapeutics to Present Initial Data from Phase 1a Trial of STAR-0310 at Upcoming European Academy of Dermatology & Venereology Congress 2025
Base Metals Investing

Astria Therapeutics to Present Initial Data from Phase 1a Trial of STAR-0310 at Upcoming European Academy of Dermatology & Venereology Congress 2025

Astria Therapeutics to Present at Upcoming Cantor Global Healthcare Conference
Base Metals Investing

Astria Therapeutics to Present at Upcoming Cantor Global Healthcare Conference

Astria Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
Base Metals Investing

Astria Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Corporate Update

Astria Therapeutics to Present at Upcoming Jefferies Healthcare Conference
base metals investing

Astria Therapeutics to Present at Upcoming Jefferies Healthcare Conference

Astria Therapeutics to Present at Upcoming Eastern Allergy Conference
base metals investing

Astria Therapeutics to Present at Upcoming Eastern Allergy Conference

Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress
base metals investing

Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES